Center for Orphan Drug Research

Since its inception in 2005, the Center for Orphan Drug Research (CODR) has been improving the care of individuals suffering from rare diseases through research, increased education efforts, and by taking an active role in shaping public policy applicable to rare diseases and orphan drug development.  The focus of CODR research is rare pediatric neurological disorders

Rare Disease Day 2018

Gene Therapy for Rare Diseases: Promise and Challenges

RSVP or submit an abstract

Rare Disease Day 2018February 23, 2018
11:00AM to 2:30PM
Graduate Hotel
Minneapolis MN, 55455

11:00-12:00 Poster Session
12-1:30 Lunch & Keynote
1:30-2:30 Networking

Read More

Researchers Explore New Ways to Predict and Control Seizures

Epilepsy affects approximately 1 percent of the human population, with an estimated 50 million people worldwide currently suffering from the disorder. Mayo Clinic and partners from the University of Pennsylvania School of Veterinary Medicine, the University of Minnesota College of Veterinary Medicine and College of Pharmacy, the Perelman School of Medicine at the University of Pennsylvania, and NeuroVista Corporation have been awarded $7.5 million grant (U01) from the National Institute of Neurological Disorders and Stroke, a division of the National Institutes of Health (NIH). The research involves studying new ways to predict and control epileptic seizures in dogs and people.

Make a gift!  Help support our research on rare pediatric neurological disorders.